Multidisciplinary approach and combination pharmacotherapy for the management of cardiometabolic patients

Giuseppe M C Rosano1,2, Cristiana Vitale3, Ilaria Spoletini4

  • 1Department of Human Sciences and Promotion of Quality of Life, San Raffaele Open University of Rome, Rome, Italy.

Insights

Cardiometabolic disorders frequently co-occur, necessitating a multidisciplinary approach for effective patient management. Targeting common pathways like inflammation and oxidative stress is crucial for treating these interconnected conditions.

Area of Science:

  • Cardiology
  • Endocrinology
  • Primary Care

Background:

  • Cardiometabolic disorders such as hypertension, coronary artery disease, dyslipidaemia, heart failure, and diabetes often cluster in patients.
  • This clustering indicates shared pathogenic mechanisms, including inflammation and oxidative stress.

Purpose of the Study:

  • To emphasize the need for a multidisciplinary approach in managing patients with co-occurring cardiometabolic disorders.
  • To highlight the importance of targeting common pathogenic mechanisms in treatment strategies.

Main Methods:

  • A consensus document was developed based on discussions from a forum involving experts in cardiology, endocrinology, and primary care.
  • Key highlights from the forum discussions were synthesized.

Main Results:

  • Cardiometabolic disorders often present as a cluster of related conditions in patients.
  • Therapeutic interventions targeting common pathogenic mechanisms are expected to impact multiple disorders simultaneously.
  • A combined treatment approach is superior to siloed specialty care.

Conclusions:

  • A multidisciplinary approach is essential for managing patients with complex cardiometabolic conditions.
  • Interventions addressing shared pathways like inflammation and oxidative stress are vital for comprehensive cardiometabolic care.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
41
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
107
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34